Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Haian Pharmaceutical is a prominent subsidiary of the Yangzijiang Pharmaceutical Group, based in Nantong, China. The company focuses on the development and production of high-quality chemical pharmaceuticals, particularly in the fields of gastroenterology, anesthesiology, and cardiovascular health. It operates advanced manufacturing facilities that comply with international GMP standards, supporting both domestic supply and global export initiatives. As a key production base for the parent group, it contributes significantly to the commercialization of blockbuster generics and improved formulations. The company's portfolio includes well-known products such as Esomeprazole Sodium and Dexmedetomidine. Jiangsu Haian is recognized as a national high-tech enterprise, emphasizing continuous improvement in pharmaceutical manufacturing technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江苏海岸药业.